Market Overview
In today's tumultuous trading session, the markets were a theater of geopolitical tensions and sector-specific rotations, leaving investors to navigate a complex landscape of opportunities and risks. The escalating US-Iran tensions cast a long shadow over global markets, exacerbating inflationary pressures and fueling volatility across asset classes. Amidst this backdrop, the Dow Jones Industrial Average and the S&P 500 managed to eke out gains, buoyed by a rally in tech stocks and semiconductors, while energy and airline sectors experienced notable fluctuations. The tech sector emerged as a beacon of resilience, with Anthropic's IPO filing igniting investor interest. The AI company's strategic positioning and financial disclosures, despite leaving its valuation shrouded in mystery, underscored the sector's potential for robust growth. This optimism was mirrored in the semiconductor space, where the PHLX Semiconductor Index surged by 2.8%, driven by the burgeoning demand for AI-related components. However, Meta Platforms bucked the trend, its stock declining by 1.9% following announcements of substantial stock offerings, highlighting the nuanced investor sentiment towards tech giants amidst broader sector enthusiasm. In contrast, the energy sector grappled with the geopolitical headwinds, as escalating tensions in the Middle East threatened to disrupt oil supplies, keeping crude prices on edge. Meanwhile, the airline industry faced its own set of challenges, with sector-specific dynamics overshadowed by broader economic uncertainties. Corporate developments added another layer of complexity to the day's trading narrative. DoorDash's advanced talks to acquire Instacart signaled a significant consolidation move in the food delivery space, potentially reshaping competitive dynamics. This news, coupled with Microsoft's strategic downsizing through buyout offers to 60,000 employees, reflected a broader trend of corporate recalibration in response to evolving market conditions. Across the Atlantic, Brazil's financial markets endured a historic rout following President Luiz Inácio Lula da Silva's unexpected election victory. The real's sharp depreciation and the benchmark stock index's steep decline underscored the market's sensitivity to political shifts, highlighting the intricate interplay between domestic politics and global financial markets. As investors digest today's developments, the interconnection between macroeconomic forces and corporate strategies remains a critical focal point. The unfolding geopolitical landscape, coupled with sector-specific trends and corporate maneuvers, will continue to shape market trajectories. Looking ahead, investors are poised on the cusp of uncertainty, with the need for strategic agility and a keen eye on global developments more pressing than ever.
In today's volatile after-hours trading session, the US stock market was significantly influenced by geopolitical tensions and sector-specific dynamics. The escalating US-Iran tensions heightened market volatility, particularly impacting the energy sector, which saw a modest gain of 0.45% as reflected in the XLE ETF. This uptick can be attributed to concerns over potential disruptions in oil supplies, keeping crude prices on edge. Meanwhile, the tech sector demonstrated resilience, with the XLK ETF surging by 1.69%. This rally was fueled by investor enthusiasm surrounding Anthropic's IPO filing and a broader demand for AI-related components, as evidenced by the PHLX Semiconductor Index's 2.8% rise. However, Meta Platforms' stock decline of 1.9% highlighted nuanced investor sentiment towards tech giants, despite the sector's overall optimism. The industrial sector, represented by the XLI ETF, also experienced a notable increase of 1.42%, possibly driven by strategic corporate developments such as DoorDash's potential acquisition of Instacart. This move signals a significant consolidation in the food delivery space, reflecting broader trends of corporate recalibration. Conversely, the consumer staples sector, with a slight decline in the XLP ETF, and the utilities sector, with a negligible drop in the XLU ETF, remained relatively subdued amidst the broader market fluctuations. Looking ahead, the interplay between geopolitical developments and sector-specific trends will likely continue to shape market trajectories. Investors will need to remain agile, closely monitoring global events and corporate strategies to navigate the ongoing uncertainty. The momentum observed in tech and industrial sectors may persist, while energy remains sensitive to geopolitical shifts, underscoring the need for strategic vigilance in the coming trading sessions.
Market Insights
U.S. equities edged higher in subdued trading, with the advance largely driven by tech megacaps, while broader market participation waned. More than two-thirds of gainers advanced on below-average volume, indicating a lack of institutional engagement despite the green tape. The volume breadth showed a significant divergence, with only 19.5% of stocks experiencing above-average volume gains, suggesting that institutional desks remained largely on the sidelines. This lack of participation raises concerns about the sustainability of the market's upward trajectory, as the absence of volume confirmation leaves the market vulnerable to sharp reversals if macroeconomic headlines trigger sudden selling. High-beta stocks, with an average return of 1.02%, outperformed the broader market, highlighting the potential for higher returns in volatile conditions. In contrast, mega-caps underperformed with an average return of 0.73%, indicating potential challenges in large-cap performance. The beta cohorts reveal that high-beta stocks did the heavy lifting, while defensive cohorts lagged behind. Despite the market's superficial favor towards bulls, the lack of volume confirmation and the underperformance of mega-caps suggest caution, as the market remains susceptible to sudden shifts driven by macroeconomic developments.
Next Day Option Data
QQQ
SPY
IWM
6-K/8-K Form Update
DG
Dollar General Corporation faces a lawsuit from the Federal Trade Commission and various states, alleging violations of the FTC Act, the Gramm-Leach-Bliley Act, and state consumer protection laws. The company has been cooperating with the FTC's investigation into its marketing and sales practices, following a Civil Investigative Demand in February 2026. Despite efforts to resolve the matter, the lawsuit, filed on October 26, 2026, seeks injunctive relief, monetary judgment, and civil penalties, potentially impacting Dollar General's financial statements.
EQ
Equillium, Inc. secured compliance with the milestone event in its single ascending dose trial of EQ504 in Australia, dosing the first patient on October 26, 2026. The company raised up to $20.0 million through the issuance of shares and pre-funded warrants, with investors waiving the Price Threshold Requirement, to fund EQ504 development and other corporate purposes. This capital infusion follows a private placement agreement contingent on the milestone event, facilitating continued progress in clinical trials.
GOAI
Eva Live Inc. issued a second Secured Convertible Promissory Note to Streeterville Capital, LLC, totaling $2.16 million on July 23, 2026. Streeterville Capital declared a "Restricted Issuance" on October 2, 2026, due to a transaction disclosed on October 8, 2026, triggering a 10% increase in the note's outstanding balance, raising it from approximately $7.42 million to $8.16 million. Eva Live Inc. disputes this assertion and is exploring options to contest the increase.
YHNAU
YHN Acquisition I Limited faces imminent delisting from Nasdaq due to failure to meet minimum market value requirements. The company did not regain compliance within the 180-day period, leading to the suspension of trading on October 30, 2026, and a pending Form 25-NSE filing for deregistration. Despite the delisting, YHN Acquisition I Limited plans to seek quotation on the OTC Markets, although this is not guaranteed, and business operations and shareholder rights remain unaffected.
FLDDW
Fold Holdings, Inc. approved a reverse stock split of its common stock, with the ratio to be determined by the Board post-approval. The special meeting saw Proposal One pass with 43.1 million votes in favor, exceeding the required two-thirds majority. Proposal Two, to adjourn the meeting if necessary, also passed with 43.1 million votes in favor, ensuring the company can solicit additional proxies if needed.
SORNU
Soren Acquisition Corp. implemented a leadership transition, appointing Arghavan Di Rezze as Chief Executive Officer and Roger Cloutier Jr. as Chief Financial Officer. Spencer Gerrol and Charles N. Kahn III transitioned to director roles, while Jamie Weber resigned as CFO. New directors Austin Criden and Joseph Tonnos, with Tonnos bringing over 15 years of SPAC experience, will receive indirect economic interests in founder shares and enter standard indemnity agreements.
EAF
GrafTech International Ltd. updated its Form 8-K/A filing to disclose non-cash charges related to the planned closure of its Monterrey, Mexico facility, estimated between $25 million and $35 million, including fixed asset write-offs and accelerated depreciation. The company anticipates total cash expenditures for the closure to be between $20 million and $25 million, primarily by the end of 2027. GrafTech reaffirms its manufacturing footprint and cost structure post-closure, while acknowledging risks and uncertainties that could affect the timing and execution of the closure.
MCRB
Seres Therapeutics, Inc. announced the resignation of Marella Thorell, Executive Vice President and Chief Financial Officer, effective November 15, 2026. The company disclosed this material change in its executive officers under Item 5.02 of Form 8-K, with plans for Thorell to provide advisory services during a transition period. The Delaware corporation, listed on the Nasdaq Global Select Market under ticker symbol MCRB, is working to ensure a smooth transition.
HTO
H2O America reported third-quarter 2026 diluted EPS of $0.99 and adjusted diluted EPS of $1.04, down from $1.27 in the same period last year. Year-to-date 2026 diluted EPS was $2.13, adjusted to $2.30, compared to $2.48 and $2.53, respectively, last year. The company narrowed standalone 2026 adjusted diluted EPS guidance to $3.10-$3.16, excluding Quadvest and pending Cibolo Valley acquisitions, and initiated guidance of $2.91-$2.97, including these impacts.
SNTI
Senti Biosciences Holdings, Inc. completed a merger transaction as outlined in the July 14, 2026, Merger Agreement. The deal involved Senti Holdings, Inc., Senti Biosciences, Inc., ST NewCo Limited, and Senti Merger Sub, Inc., resulting in Midco merging into Merger Sub and becoming a wholly owned subsidiary of ST NewCo Limited. In connection with the merger, Midco issued Contingent Value Rights (CVRs) to facilitate milestone-based payments, contingent on regulatory approvals and sales targets.
RENT
Rent the Runway, Inc. completed a $15 million rights offering, resulting in the subscription of 2.5 million shares at gross proceeds of approximately $8.9 million. The Investor Group, including CHS US Investments LLC, Gateway Runway, LLC, and STORY3, agreed to purchase all unsubscribed shares at $3.55 per share, issuing 1.7 million shares for gross proceeds of about $6.1 million. The company filed an 8-K report on October 20, 2026, disclosing the rights offering and backstop commitment details, in compliance with the Securities Exchange Act of 1934.
JBLU
JetBlue reported strong revenue growth in its 3Q26 earnings presentation, with RASM up 18.4% year-over-year, driven by a 20% yield increase and broad-based revenue strength. The company expects a 1-2 point expansion in adjusted operating margin for 4Q despite an 85% YoY rise in fuel prices. JetBlue's JetForward initiatives are on track to deliver $310M in incremental EBIT in 2026, with a target of $1.2B in incremental EBIT and at least $1.00 EPS by 2028.
NTCT
NetScout Systems, Inc. announced the immediate resignation of its Chief Operating Officer, Sanjay Munshi, and filed Form 8-K to report the departure and appointment of Anthony Piazza as Executive Vice President and Chief Financial Officer. The company confirmed compliance with the Securities Exchange Act of 1934 and clarified that it is not classified as an emerging growth company under SEC definitions.
RMBS
Rambus Inc. reported record third-quarter 2026 revenue of $218.3 million, up 22% year over year, surpassing guidance. The company achieved GAAP diluted earnings per share of $0.69 and non-GAAP diluted earnings per share of $0.84, both exceeding expectations. Product revenue rose 15% quarter over quarter and 22% year over year, while royalties revenue reached $77.0 million. Rambus generated $102.5 million in cash from operations, driven by strong customer demand, and plans to expand offerings for next-generation AI systems.
BRX
Brixmor Property Group Inc. reported third-quarter 2026 results, highlighting strong leasing demand that drove occupancy to record highs of 95.6%, with anchor occupancy at 97.0%. The company executed 1.6 million square feet of new and renewal leases, boosting total leased occupancy. Net income was $0.28 per diluted share, with Nareit FFO at $0.60 per diluted share. Brixmor announced the Slate Transaction, acquiring a 23-property grocery-anchored portfolio for approximately $636 million and securing a 20% equity interest in a joint venture for an additional 92 properties, expected to close in Q1 2027. The company increased its quarterly dividend by 7.3% to $0.3300 per share, representing an annualized yield of approximately 4.7%.
BOF
BranchOut Food Inc. has entered into an underwriting agreement with Lake Street Capital Markets LLC to issue and sell 2,941,177 Firm Shares of its common stock at $1.581 per share, representing 93% of the public offering price. The company has filed a registration statement on Form S-3 with the SEC, effective October 16, 2026, registering up to $50 million in aggregate offering amount of common stock, warrants, and units. Lake Street Capital Markets LLC has been granted an over-allotment option to purchase up to 441,176 additional shares, representing 15% of the Firm Shares sold, at the same purchase price.
CTXR
Citius Oncology, Inc. reported a 120% growth in LYMPHIR unit sales and vial orders for the fiscal fourth quarter ended September 30, 2026, with 792 units purchased by wholesalers and 950 vials ordered by prescribing centers. The company noted an increase in institutional orders from 44 to 54 since August 14, 2026, and anticipates continued demand and sales growth as LYMPHIR gains traction in treating cutaneous T-cell lymphoma. These preliminary figures are pending final audit and year-end closing procedures.
SLXNW
Silexion Therapeutics Corp approved a significant capital increase, raising its authorized capital from US$2.15 million to US$69.65 million by issuing 500 million additional ordinary shares at a par value of US$0.135 each. The company also executed a 1-for-24 reverse share split, adjusting the share price to US$3.24. Both proposals passed with majority shareholder approval, facing minimal opposition.
AGYS
Agilysys, Inc. reported record fiscal 2027 second-quarter results, with total net revenue increasing 17.7% to $93.4 million. Recurring revenue, comprising subscription and maintenance charges, reached $62.2 million, representing 66.6% of total net revenue. The company raised its full-year guidance, expecting total revenue between $374 million and $378 million, with subscription revenue growth at least 34% year-over-year and Adjusted EBITDA at 25% of revenue.
DVLT
Datavault AI Inc. disclosed a securities purchase agreement with Scilex for 15 million shares and a warrant for 263.9 million shares, valued at $150 million in Bitcoin. Following a review, Datavault AI sold 491.431 Bitcoin back to Scilex for approximately $40.5 million in cash due to non-compliance with digital asset recognition requirements. The company is also unable to withdraw Bitcoin from its Biconomy wallet, with preliminary restatements expected to reduce total assets by up to $92.2 million as of December 31, 2025.
WLFC
Willis Lease Finance Corporation will release its third-quarter 2026 financial results before the market opens on November 3, 2026. The company will host a conference call at 10:00 a.m. Eastern Time on the same day, led by its executive management team, to discuss the results. The press release, issued on October 26, 2026, will detail the financial outcomes prior to the call.
AIXC
FF EAI Robotics Ecosystem Inc. has agreed to acquire FF EAI Robotics Inc. in a transaction involving Faraday Future Intelligent Electric Inc., Yueting Jia, and Jiawei Wang. The deal, structured under a Support Agreement, includes the issuance of Purchaser Stock Consideration and the merger of the target company into Merger Sub, contingent on certain conditions. Stockholders have committed to supporting necessary stockholder proposals and restricting share transfers until the Expiration Time, with specific exceptions.
CHCO
City Holding Company announced record quarterly results for the third quarter ended September 30, 2026, with net income of $34.6 million and diluted earnings of $2.43 per share. Net interest income rose 3.0% to $62.6 million, while non-interest income increased 4.5% to $21.4 million, driven by higher service charges and wealth management fees. Non-interest expenses grew 8.5% to $40.9 million, mainly due to increased salaries and operating costs. The loan-to-deposit ratio remained stable at 84.9%, and total average depository balances increased 0.5% to $5.35 billion. The Board approved a quarterly cash dividend of $1.00 per share, marking a 15% increase from the previous payment.
YHC
LQR House Inc. has expanded its agreement with subsidiary YHC AI Limited to acquire up to $5 million in AI computing resources from OpenAI, enhancing AI-driven research and analytics at Fusion Five Continents Securities Limited. The revised deal increases the AI compute purchase limit, introduces a volume discount for purchases between $3 million and $5 million, and offers a 40% discount for aggregate purchases within this range, while maintaining a 30% discount for purchases below $3 million.
GIXXR
GigCapital9 Corp. has entered into a non-binding Letter of Intent with a leading clean energy technology company, proposing a $600 million business combination plus a $100 million earnout. The transaction aims to bring GigCapital9's clean energy technology to public markets, supporting the commercialization of clean power applications driven by AI demand and contributing to a sustainable energy future. The deal's completion is contingent on negotiations, regulatory approvals, and shareholder consent.
SGRY
Surgery Partners, Inc. agreed to merge with Spyglass Topco, LLC, Spyglass Merger Subsidiary, Inc., and Bon Secours Mercy Health, Inc., forming the Surviving Corporation. At the Effective Time, each share of Surgery Partners' common stock will be converted into $23.50 in cash, with exceptions for appraisal rights and treasury shares. The Board of Directors has recommended the merger, subject to certain conditions, and advised stockholders to approve the transaction.
NATH
Nathan's Famous Inc. completed a merger with Boardwalk Merger Sub Inc., a wholly-owned subsidiary of Smithfield Foods, Inc., resulting in each share of Nathan's Famous common stock being converted into $102.00 in cash. The merger led to the cancellation of all common stock and the appointment of C. Shane Smith as the sole director of the Surviving Corporation. Nathan's Famous notified Nasdaq to suspend trading and requested deregistration of its common stock from the exchange.
FRMM
Forum Markets, Incorporated (FRMM) has entered into a definitive agreement with Fireworks AI for a 36-month reservation of 96 enterprise AI servers at a Dallas, Texas data center, with a total contract value of approximately $94.4 million. The deal includes a substantial prepayment deposit, with GPU deployment expected in late December or early January. This partnership is part of Forum Edge AI LLC's AI infrastructure strategy and marks the first finalized contract executed under their footprint.
ASPI
ASP Isotopes Inc. achieved stable production of liquid helium at its Virginia Gas Project in South Africa, marking a significant milestone for both Renergen and ASP Isotopes. The Phase 1 plant is now operational, with helium accumulating in cryogenic storage ahead of initial deliveries under existing agreements. This project, South Africa's first onshore petroleum production right, is also the country's first integrated producer of both liquid helium and liquefied natural gas (LNG).
ORKA
Oruka Therapeutics, Inc. announced promising Week 16 results from its Phase 2b EVERLAST-B clinical trial of ORKA-001, an investigational IL-23p19 monoclonal antibody, for moderate-to-severe plaque psoriasis. The trial showed 61% of patients in the 600 mg group achieved PASI 100, significantly outperforming the placebo group (p<0.0001). Oruka plans to initiate Phase 3 trials in early 2027 and expects to report 52-week results in December 2026.
GGB
Gerdau S.A. reported third quarter 2026 results, showing an Adjusted EBITDA of R$3.8 billion, up 9.9% from the previous quarter and 37.8% higher than the same period last year, with a margin of 20.2%, the highest since Q2 2023. Net sales reached R$18.7 billion, up 4.6% from the prior quarter, while adjusted net income was R$1.5 billion, up 3.9%. The company approved a dividend of R$667.0 million, equivalent to R$0.34 per share, to be paid on December 15, 2026.
SLBT
SL Science Holding Limited disclosed unaudited interim consolidated financial statements for the six months ended June 30, 2026, in a 6-K filing. The report highlighted its new product pipeline, including exosome concentrate and cancer therapies, and detailed related party transactions with JiYanBiomedicalCo.Ltd and SlBioTaiwanMember. The company also announced the issuance of a press release on October 26, 2026, regarding these financials.
ASND
Ascendis Pharma A/S reported significant improvements in kidney function among adults with hypoparathyroidism treated with TransCon PTH in Phase 2 and 3 trials. The pooled analysis showed statistically significant increases in mean estimated glomerular filtration rate (eGFR) from baseline to Week 26 (7.2 mL/min/1.73 m²) and Week 52 (9.6 mL/min/1.73 m²), with 68.9% of patients achieving clinically meaningful improvements by Week 52. Additionally, 24-hour urine calcium excretion normalized by Week 26, and most patients achieved independence from active vitamin D and therapeutic doses of calcium by the final trial visit.
TCKRF
Teck Resources Limited faces operational disruptions as strike action commenced at its Highland Valley Copper Operations in British Columbia, reducing operations to limited capacity. The company has implemented contingency plans to ensure safety and environmental management during the labor action. Teck remains committed to negotiating a fair collective agreement while maintaining operational viability, though production impacts and negotiation outcomes are uncertain.
ACB
Aurora Cannabis Inc. secured compliance as the Alberta Securities Commission dismissed Curaleaf's application to halt its at-the-market (ATM) program. Aurora reaffirmed that the ATM was last used on August 18, 2026, and has not been utilized during Curaleaf's Hostile Bid process. The Board unanimously recommended shareholders reject Curaleaf's bid, emphasizing the ATM program was established in February 2026 to enhance strategic flexibility, including cultivation and M&A opportunities.
SVREW
SaverOne 2014 Ltd. launched a software-only version of its driver distraction prevention solution on October 26, 2026. The platform-independent solution targets commercial fleets, private vehicles, and insurance providers, eliminating the need for dedicated in-vehicle hardware. By integrating with existing telematics and in-vehicle platforms, SaverOne aims to prevent phone distraction while driving, with partnerships including Ituran, Geotab, and a leading global commercial vehicle manufacturer, potentially reaching millions of vehicles.
COCSF
Coca-Cola FEMSA reported third-quarter 2026 results, with volume up 5.3% and revenue rising 10.9% on a currency-neutral basis, reaching 11.3%. Operating income increased 15.4% on a currency-neutral basis, reaching 16.4%. For the first nine months, volume grew 3.4%, revenue increased 6.2% on a currency-neutral basis to 10.4%, and operating income rose 8.0% on a currency-neutral basis to 11.9%, with majority net income up 2.7%.
WSAT
WISeSat.Space Holdings Corp. agreed to acquire satellite capacity from SEALSQ Corp in a $15 million transaction. The deal aims to establish the Quantum Spatial Orbital Cloud (QSOC) infrastructure, supporting WISeSat.Space's commercial development. This follows WISeSat.Space's Nasdaq debut on October 2, 2026, and SEALSQ's $10 million investment in the company.
ITUB
Itaú Unibanco Holding S.A. agreed to acquire all shares of NeoSpace A.I. Technologies Ltda. for BRL 2.925 billion, pending approvals from the Brazilian Antitrust Authority and the Central Bank of Brazil. The acquisition aims to bolster Itaú's generative AI capabilities, enhancing services in credit, CRM, and fraud prevention, while NeoSpace's management and operations will remain autonomous. The transaction is expected to close following regulatory approvals.
RDPTF
Radiopharm Theranostics Limited secured an $8 million advance on its FY26 Research and Development Tax Incentive (RDTI) from Rockford Capital. The funding, secured against anticipated RDTI, supports the company's clinical trial pipeline and general working capital. The advance, repayable by October 26, 2027, can be settled earlier without penalty, following the Australian Government's RDTI program offering up to a 43.5% refundable tax offset.
OMH
Ohmyhome Limited, now Ohmyswift Limited, secured shareholder approval to relocate from the Cayman Islands to the British Virgin Islands. The name change garnered 2,765,972 votes in favor, while the migration proposal received 2,764,978 votes in favor. Additionally, the chairman was authorized to adjourn the meeting if necessary, with 2,765,086 votes supporting this measure.
AZUXY
Azul S.A. has secured a financing facility of up to R$2.0 billion, backed by the Brazilian Federal Government through ABGF, using resources from the Export Guarantee Fund. The net proceeds will be used exclusively for purchasing aviation fuel for its domestic operations. This move aligns with Azul's long-term strategy, enhancing its liquidity and financial flexibility amid volatile fuel prices, reinforcing management's confidence in its strategic and liquidity position.
IMTX
Immatics N.V. disclosed updated clinical trial data for its phase 1b study of IMA402 PRAME TCR bispecific in a heavily pretreated patient population, primarily with melanoma and ovarian cancer. As of June 1, 2026, 126 patients received at least one infusion, with 40 in the efficacy population treated at the recommended Phase 2 dose range. IMA402 demonstrated favorable tolerability, with transient lymphopenia and low-grade cytokine release syndrome as the most frequent adverse events. The treatment showed promising anti-tumor activity, achieving a confirmed objective response rate of 25% and a disease control rate of 63% in the efficacy population.